Đang chuẩn bị liên kết để tải về tài liệu:
Factors associated with serum CA125 level in women without ovarian cancer in the United States: A population-based study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Cancer antigen 125 (CA125) is clinically used to monitor response to therapy in ovarian cancer and has been proposed for use in detecting ovarian cancer. This population-based study examines how demographic characteristics, gynecologic/ reproductive history, chronic non-malignant medical conditions, history of non-ovarian cancer, lifestyle practices, and biomarkers of inflammation correlate with serum CA125 in both premenopausal and postmenopausal women without ovarian cancer across the United States. |